Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |